Insider filing
Traded Sep 11 · filed 3 days later
Routine share withholding; mechanical by default.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Aug 31, 2026 · Filed Aug 31, 2026
Edwards Lifesciences's SVP, Corporate Controller sold $50K of Edwards Lifesciences shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$49,534
Shares × reported transaction price
39 days after results of Jul 23, 2026, 65 days before results of Nov 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $90.75 on Aug 31, 2026, within 5% of its 52-week high, after a 7% rise over the previous 30 trading days
52-week range $72.65 (Oct 16, 2025) to $95.18 (Jul 6, 2026), 80% of the way up, from 251 adjusted closes. 30 trading days earlier: $85.00 on Jul 20, 2026. Describes the past only, not a forecast
RSI 54, 7% above its 200-day average, 1% above its 50-day average, 5% below the 52-week high, 20-day volatility 18% a year, against the S&P 500: +3 points over 1 month, +2 points over 3 months, −8 points over 6 months
From the adjusted closes up to Aug 31, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Oct 14, 2024 in the U.S. District Court, C.D. California. A filing is an allegation, not a finding.
Dhimant Patel v. Edwards Lifesciences Corporation, docket 8:24-cv-02221, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −4.4% | +0.6% | −5.0% |
| 30 days | −6.1% | +0.3% | −6.4% |
Past results only. Not a forecast.
Insider filing
Traded Sep 11 · filed 3 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Sep 14 · filed the same day
Routine share withholding; mechanical by default.
Insider filing
Traded Sep 13 · filed 1 day later
Routine share withholding; mechanical by default.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.